Rethinking bioequivalence and equivalence requirements of orally inhaled drug products

Orally inhaled drug products (OIPs), such as corticosteroids and bronchodilators, are at the forefront of asthma and chronic obstructive pulmonary disease treatments, two diseases that afflict worldwide populations. Introducing generics of these products is essential, as the pricing of these medicat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dina Al-Numani (Autor), Philippe Colucci (Autor), Murray P. Ducharme (Autor)
Formato: Libro
Publicado: Elsevier, 2015-12-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible